<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26155935</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1297-9716</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>46</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jul</Month>
              <Day>08</Day>
            </PubDate>
          </JournalIssue>
          <Title>Veterinary research</Title>
          <ISOAbbreviation>Vet Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recent advances in Brucella abortus vaccines.</ArticleTitle>
        <Pagination>
          <StartPage>76</StartPage>
          <MedlinePgn>76</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">76</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-015-0199-7</ELocationID>
        <Abstract>
          <AbstractText>Brucella abortus vaccines play a central role in bovine brucellosis control/eradication programs and have been successfully used worldwide for decades. Strain 19 and RB51 are the approved B. abortus vaccines strains most commonly used to protect cattle against infection and abortion. However, due to some drawbacks shown by these vaccines much effort has been undertaken for the development of new vaccines, safer and more effective, that could also be used in other susceptible species of animals. In this paper, we present a review of the main aspects of the vaccines that have been used in the brucellosis control over the years and the current research advances in the development of new B. abortus vaccines.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dorneles</LastName>
            <ForeName>Elaine M S</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Medicina Veterinária Preventiva, Escola de Veterinária, Laboratório de Bacteriologia Aplicada, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. selesdorneles@yahoo.com.br.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sriranganathan</LastName>
            <ForeName>Nammalwar</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA. nathans@vt.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lage</LastName>
            <ForeName>Andrey P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Medicina Veterinária Preventiva, Escola de Veterinária, Laboratório de Bacteriologia Aplicada, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. alage@vet.ufmg.br.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2015</Year>
          <Month>07</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Vet Res</MedlineTA>
        <NlmUniqueID>9309551</NlmUniqueID>
        <ISSNLinking>0928-4249</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002004">Brucella Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000034" MajorTopicYN="N">Abortion, Veterinary</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002004" MajorTopicYN="N">Brucella Vaccine</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002003" MajorTopicYN="N">Brucella abortus</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002007" MajorTopicYN="N">Brucellosis, Bovine</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2014</Year>
          <Month>12</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2015</Year>
          <Month>5</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26155935</ArticleId>
        <ArticleId IdType="pmc">PMC4495609</ArticleId>
        <ArticleId IdType="doi">10.1186/s13567-015-0199-7</ArticleId>
        <ArticleId IdType="pii">10.1186/s13567-015-0199-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Corbel MJ, Elberg SS, Cosivi O.  Brucellosis in humans and animals. Geneva: World Health Organization; 2006. </Citation>
        </Reference>
        <Reference>
          <Citation>Schurig G, Boyle S, Sriranganathan N. Brucella abortus vaccine strain RB51: a brief review. Arch Med Vet. 1995;27:19–22.</Citation>
        </Reference>
        <Reference>
          <Citation>Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev. 2003;16:65–78. doi: 10.1128/CMR.16.1.65-78.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.16.1.65-78.2003</ArticleId>
            <ArticleId IdType="pmc">PMC145300</ArticleId>
            <ArticleId IdType="pubmed">12525425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC, Stoffregen WS. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines. 2005;4:915–928. doi: 10.1586/14760584.4.6.915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.4.6.915</ArticleId>
            <ArticleId IdType="pubmed">16372886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicoletti P.  Vaccination. In: Nielsen K, Duncan JR, editors. Animal Brucellosis. Boca Raton: CRC Press; 1990. </Citation>
        </Reference>
        <Reference>
          <Citation>Poester FP, Goncalves VS, Paixao TA, Santos RL, Olsen SC, Schurig GG, Lage AP. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. Vaccine. 2006;24:5327–5334. doi: 10.1016/j.vaccine.2006.04.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2006.04.020</ArticleId>
            <ArticleId IdType="pubmed">16713034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC, Bricker B, Palmer MV, Jensen AE, Cheville NF. Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy. Res Vet Sci. 1999;66:101–105. doi: 10.1053/rvsc.1998.0251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/rvsc.1998.0251</ArticleId>
            <ArticleId IdType="pubmed">10208887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thakur A, Pedersen LE, Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine. 2012;30:4907–4920. doi: 10.1016/j.vaccine.2012.05.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.05.049</ArticleId>
            <ArticleId IdType="pubmed">22658928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miranda KL, Dorneles EM, Pauletti RB, Poester FP, Lage AP. Brucella abortus S19 and RB51 vaccine immunogenicity test: evaluation of three mice (BALB/c, Swiss and CD-1®) and two challenge strains (544 and 2308) Vaccine. 2015;33:507–511. doi: 10.1016/j.vaccine.2014.11.056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.11.056</ArticleId>
            <ArticleId IdType="pubmed">25498211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Yoldi D, Le Fleche P, Marin CM, De Miguel MJ, Munoz PM, Vergnaud G, Lopez-Goni I. Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis. Vaccine. 2007;25:2858–2862. doi: 10.1016/j.vaccine.2006.09.063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2006.09.063</ArticleId>
            <ArticleId IdType="pubmed">17050051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miranda KL, Poester FP, Minharro S, Dorneles EM, Stynen AP, Lage AP. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping. Vaccine. 2013;31:3014–3018. doi: 10.1016/j.vaccine.2013.04.054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2013.04.054</ArticleId>
            <ArticleId IdType="pubmed">23664986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorneles EM, de Faria AP, Pauletti RB, Santana JA, Caldeira GA, Heinemann MB, Titze-de-Almeida R, Lage AP. Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16) Vaccine. 2013;31:4856–4859. doi: 10.1016/j.vaccine.2013.07.063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2013.07.063</ArticleId>
            <ArticleId IdType="pubmed">23933375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira SC, Harms JS, Banai M, Splitter GA. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell Immunol. 1996;172:262–268. doi: 10.1006/cimm.1996.0241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/cimm.1996.0241</ArticleId>
            <ArticleId IdType="pubmed">8964089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira SC, Splitter GA. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine. 1996;14:959–962. doi: 10.1016/0264-410X(96)00018-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0264-410X(96)00018-7</ArticleId>
            <ArticleId IdType="pubmed">8873388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, Duncan AJ, Boyle SM, Sriranganathan N, Toth TE, Schurig GG. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun. 1998;66:5684–5691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC108718</ArticleId>
            <ArticleId IdType="pubmed">9826342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, Cravero S, Calvert CL, Toth TE, Sriranganathan N, Boyle SM, Rossetti OL, Schurig GG. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol. 2000;7:114–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC95834</ArticleId>
            <ArticleId IdType="pubmed">10618289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, He Y, Buccolo LS, Boyle SM, Sriranganathan N, Schurig GG. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun. 2000;68:3927–3932. doi: 10.1128/IAI.68.7.3927-3932.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.68.7.3927-3932.2000</ArticleId>
            <ArticleId IdType="pmc">PMC101669</ArticleId>
            <ArticleId IdType="pubmed">10858205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, He Y, Cravero S, Sriranganathan N, Boyle SM, Schurig GG. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun. 2000;68:3286–3289. doi: 10.1128/IAI.68.6.3286-3289.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.68.6.3286-3289.2000</ArticleId>
            <ArticleId IdType="pmc">PMC97582</ArticleId>
            <ArticleId IdType="pubmed">10816475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vet Microbiol. 2004;102:237–245. doi: 10.1016/j.vetmic.2004.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2004.07.001</ArticleId>
            <ArticleId IdType="pubmed">15327798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Vemulapalli R, Schurig GG. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu, Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type. Infect Immun. 2002;70:2535–2543. doi: 10.1128/IAI.70.5.2535-2543.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.70.5.2535-2543.2002</ArticleId>
            <ArticleId IdType="pmc">PMC127893</ArticleId>
            <ArticleId IdType="pubmed">11953393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun. 2001;69:4816–4822. doi: 10.1128/IAI.69.8.4816-4822.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.8.4816-4822.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98569</ArticleId>
            <ArticleId IdType="pubmed">11447155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, Walravens K, Letesson JJ. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun. 2001;69:6264–70. doi: 10.1128/IAI.69.10.6264-6270.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.10.6264-6270.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98760</ArticleId>
            <ArticleId IdType="pubmed">11553569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, Bowden RA, Bruno L, Fossati CA, Spitz M. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun. 2002;70:2507–2511. doi: 10.1128/IAI.70.5.2507-2511.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.70.5.2507-2511.2002</ArticleId>
            <ArticleId IdType="pmc">PMC127889</ArticleId>
            <ArticleId IdType="pubmed">11953389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, Bruno L, Fossati CA, Giambartolomei GH. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun. 2003;71:5750–5755. doi: 10.1128/IAI.71.10.5750-5755.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.10.5750-5755.2003</ArticleId>
            <ArticleId IdType="pmc">PMC201088</ArticleId>
            <ArticleId IdType="pubmed">14500496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onate AA, Cespedes S, Cabrera A, Rivers R, Gonzalez A, Munoz C, Folch H, Andrews E. A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun. 2003;71:4857–4861. doi: 10.1128/IAI.71.9.4857-4861.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.9.4857-4861.2003</ArticleId>
            <ArticleId IdType="pmc">PMC187304</ArticleId>
            <ArticleId IdType="pubmed">12933826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baloglu S, Boyle SM, Vemulapalli R, Sriranganathan N, Schurig GG, Toth TE. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein. Vet Microbiol. 2005;109:11–17. doi: 10.1016/j.vetmic.2005.04.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2005.04.011</ArticleId>
            <ArticleId IdType="pubmed">15941627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun. 2006;74:2734–2741. doi: 10.1128/IAI.74.5.2734-2741.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.74.5.2734-2741.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1459688</ArticleId>
            <ArticleId IdType="pubmed">16622210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews E, Salgado P, Folch H, Onate A. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide-dismutase: II. Induction of specific CD8+ cytotoxic lymphocytes and sensitized CD4+ IFN-gamma-producing cell. Microbiol Immunol. 2006;50:389–393. doi: 10.1111/j.1348-0421.2006.tb03805.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.2006.tb03805.x</ArticleId>
            <ArticleId IdType="pubmed">16714846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez-Smith A, Vemulapalli R, Andrews E, Onate A. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2. Immunobiology. 2006;211:65–74. doi: 10.1016/j.imbio.2005.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imbio.2005.09.004</ArticleId>
            <ArticleId IdType="pubmed">16446171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Becker T, Walters N, Pascual DW. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun. 2006;74:3874–3879. doi: 10.1128/IAI.01957-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01957-05</ArticleId>
            <ArticleId IdType="pmc">PMC1489696</ArticleId>
            <ArticleId IdType="pubmed">16790759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine. 2007;25:6721–6729. doi: 10.1016/j.vaccine.2007.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2007.07.002</ArticleId>
            <ArticleId IdType="pubmed">17686554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu DH, Hu XD, Cai H. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses. DNA Cell Biol. 2007;26:435–443. doi: 10.1089/dna.2006.0552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dna.2006.0552</ArticleId>
            <ArticleId IdType="pubmed">17570767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu DH, Li M, Hu XD, Cai H. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector. Vaccine. 2007;25:6744–6754. doi: 10.1016/j.vaccine.2007.06.061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2007.06.061</ArticleId>
            <ArticleId IdType="pubmed">17681650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu XD, Yu DH, Chen ST, Li SX, Cai H. A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle. DNA Cell Biol. 2009;28:191–199. doi: 10.1089/dna.2008.0790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/dna.2008.0790</ArticleId>
            <ArticleId IdType="pubmed">19364278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabrera A, Saez D, Cespedes S, Andrews E, Onate A. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice. Immunobiology. 2009;214:467–474. doi: 10.1016/j.imbio.2008.11.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imbio.2008.11.016</ArticleId>
            <ArticleId IdType="pubmed">19150742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC, Boyle SM, Schurig GG, Sriranganathan NN. Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol. 2009;16:535–540. doi: 10.1128/CVI.00419-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00419-08</ArticleId>
            <ArticleId IdType="pmc">PMC2668271</ArticleId>
            <ArticleId IdType="pubmed">19176693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquevich KA, Estein SM, Garcia Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun. 2009;77:436–445. doi: 10.1128/IAI.01151-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01151-08</ArticleId>
            <ArticleId IdType="pmc">PMC2612246</ArticleId>
            <ArticleId IdType="pubmed">18981242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella. Vaccine. 2009;27:5214–5219. doi: 10.1016/j.vaccine.2009.06.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2009.06.075</ArticleId>
            <ArticleId IdType="pubmed">19596411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquevich KA, Ibanez AE, Coria LM, Garcia Samartino C, Estein SM, Zwerdling A, Barrionuevo P, Oliveira FS, Seither C, Warzecha H, Oliveira SC, Giambartolomei GH, Cassataro J. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One. 2011;6 doi: 10.1371/journal.pone.0016203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0016203</ArticleId>
            <ArticleId IdType="pmc">PMC3021544</ArticleId>
            <ArticleId IdType="pubmed">21264260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singha H, Mallick AI, Jana C, Fatima N, Owais M, Chaudhuri P. Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus. Vaccine. 2011;29:4720–4727. doi: 10.1016/j.vaccine.2011.04.088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.04.088</ArticleId>
            <ArticleId IdType="pubmed">21565241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma SK, Jain S, Kumar S. Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice. World J Microbiol Biotechnol. 2012;28:2487–2495. doi: 10.1007/s11274-012-1056-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11274-012-1056-8</ArticleId>
            <ArticleId IdType="pubmed">22806154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sislema-Egas F, Cespedes S, Fernandez P, Retamal-Diaz A, Saez D, Onate A. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice. Vaccine. 2012;30:7286–7291. doi: 10.1016/j.vaccine.2012.09.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.09.039</ArticleId>
            <ArticleId IdType="pubmed">23026687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JJ, Kim DH, Lee JJ, Kim DG, Min W, Lee HJ, Rhee MH, Kim S. Protective effects of recombinantBrucella abortusOmp28 against infection with a virulent strain of Brucella abortus544 in mice. J Vet Sci. 2012;13:287–292. doi: 10.4142/jvs.2012.13.3.287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4142/jvs.2012.13.3.287</ArticleId>
            <ArticleId IdType="pmc">PMC3467404</ArticleId>
            <ArticleId IdType="pubmed">23000585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saez D, Fernandez P, Rivera A, Andrews E, Onate A. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine. 2012;30:1283–1290. doi: 10.1016/j.vaccine.2011.12.088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.12.088</ArticleId>
            <ArticleId IdType="pubmed">22222868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goel D, Rajendran V, Ghosh PC, Bhatnagar R. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Vaccine. 2013;31:1231–1237. doi: 10.1016/j.vaccine.2012.12.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.12.043</ArticleId>
            <ArticleId IdType="pubmed">23273966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Afley P, Kumar S. Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice. World J Microbiol Biotechnol. 2013;29:907–913. doi: 10.1007/s11274-012-1247-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11274-012-1247-3</ArticleId>
            <ArticleId IdType="pubmed">23269507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manthei CA (1959) Summary of controlled research with strain 19, Proceedings 63rd Ann Meet US Livestock Sanitary Association.</Citation>
        </Reference>
        <Reference>
          <Citation>Buck JM. Studies on vaccination during calfhood to prevent bovine infectious abortion. J Agri Res. 1930;41:667–689.</Citation>
        </Reference>
        <Reference>
          <Citation>Graves RR. The story of John M. Buck’s and Matilda’s contribution to the cattle industry J Am Vet Med Assoc. 1943;102:193–195.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones FM, Hooper JA. Brucella abortus strain 19 calfhood vaccination – a review. Southwest Vet. 1976;29:219–225.</Citation>
        </Reference>
        <Reference>
          <Citation>McDiarmid A. The degree and duration of immunity in cattle resulting from vaccination with S. 19 Br. abortus vaccine and its implication in the future control and eventual eradication of Brucellosis. Vet Rec. 1957;69:877–879.</Citation>
        </Reference>
        <Reference>
          <Citation>Koh SH, Morley FH. The effect of calfhood vaccination with strain 19 on the serological diagnosis and eradication of bovine brucellosis. Aust Vet J. 1981;57:551–553. doi: 10.1111/j.1751-0813.1981.tb00432.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1751-0813.1981.tb00432.x</ArticleId>
            <ArticleId IdType="pubmed">7340777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mingle CK, Manthei CA, Jasmin AM. The stability of reduced virulence exhibited by Brucella abortus strain 19. J Am Vet Med Assoc. 1941;99:203–205.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyer ME, Nelson CJ. Persistence of Brucella abortus, strain 19 infection in immunized cattle. Proc Annu Meet U S Anim Health Assoc. 1969;73:159–165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4993565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breitmeyer RE, Hird DW, Carpenter TE. Serologic and bacteriologic test results after adult vaccination with strain 19 in three dairy herds infected with brucellosis. J Am Vet Med Assoc. 1992;200:806–811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1568926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicoletti P. Prevalence and persistence of Brucella abortus strain 19 infections and prevalence of other biotypes in vaccinated adult dairy cattle. J Am Vet Med Assoc. 1981;178:143–145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6782064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corner LA, Alton GG. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res Vet Sci. 1981;31:342–344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6805054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambert G, Manthei CA, Deyoe BL. Studies on Brucella abortus infection in bulls. Am J Vet Res. 1963;24:1152–1157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14081449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schurig GG, Roop RM, 2nd, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28:171–188. doi: 10.1016/0378-1135(91)90091-S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-1135(91)90091-S</ArticleId>
            <ArticleId IdType="pubmed">1908158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheville NF, Stevens MG, Jensen AE, Tatum FM, Halling SM. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am J Vet Res. 1993;54:1591–1597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8250382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle. Vet Ther. 2000;1:183–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19757581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lord VR, Schurig GG, Cherwonogrodzky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res. 1998;59:1016–1020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9706206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorneles EM, Santana JA, Alves TM, Pauletti RB, Mol JP, Heinemann MB, Lage AP. Genetic stability of Brucella abortus isolates from an outbreak by multiple-locus variable-number tandem repeat analysis (MLVA16) BMC Microbiol. 2014;14:186. doi: 10.1186/1471-2180-14-186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-14-186</ArticleId>
            <ArticleId IdType="pmc">PMC4112982</ArticleId>
            <ArticleId IdType="pubmed">25015840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheville NF, Olsen SC, Jensen AE, Stevens MG, Palmer MV, Florance AM. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am J Vet Res. 1996;57:1153–1156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8836366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer MV, Cheville NF, Jensen AE. Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings. Vet Pathol. 1996;33:682–691. doi: 10.1177/030098589603300607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/030098589603300607</ArticleId>
            <ArticleId IdType="pubmed">8952027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer MV, Olsen SC, Cheville NF. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am J Vet Res. 1997;58:472–477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9140553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins H, Garin-Bastuji B, Lima F, Flor L, Pina Fonseca A, Boinas F. Eradication of bovine brucellosis in the Azores, Portugal-Outcome of a 5-year programme (2002–2007) based on test-and-slaughter and RB51 vaccination. Prev Vet Med. 2009;90:80–89. doi: 10.1016/j.prevetmed.2009.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prevetmed.2009.04.002</ArticleId>
            <ArticleId IdType="pubmed">19439382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samartino LE, Fort M, Gregoret R, Schurig GG. Use of Brucella abortus vaccine strain RB51 in pregnant cows after calfhood vaccination with strain 19 in Argentina. Prev Vet Med. 2000;45:193–199. doi: 10.1016/S0167-5877(00)00130-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0167-5877(00)00130-6</ArticleId>
            <ArticleId IdType="pubmed">10821960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edmonds MD, Schurig GG, Samartino LE, Hoyt PG, Walker JV, Hagius SD, Elzer PH. Biosafety of Brucella abortus strain RB51 for vaccination of mature bulls and pregnant heifers. Am J Vet Res. 1999;60:722–725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10376900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, Weyant R, Bragg SL, Spiegel RA, Tappero J, Perkins BA. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22:3435–3439. doi: 10.1016/j.vaccine.2004.02.041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2004.02.041</ArticleId>
            <ArticleId IdType="pubmed">15308369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen SC, Stevens MG, Cheville NF, Schurig G. Experimental use of a dot-blot assay to measure serologic responses of cattle vaccinated with Brucella abortus strain RB51. J Vet Diagn Invest. 1997;9:363–367. doi: 10.1177/104063879700900404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/104063879700900404</ArticleId>
            <ArticleId IdType="pubmed">9376424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nielsen K, Smith P, Yu W, Nicoletti P, Elzer P, Vigliocco A, Silva P, Bermudez R, Renteria T, Moreno F, Ruiz A, Massengill C, Muenks Q, Kenny K, Tollersrud T, Samartino L, Conde S, Draghi De Benitez G, Gall D, Perez B, Rojas X (2004) Enzyme immunoassay for the diagnosis of brucellosis: chimeric Protein A-Protein G as a common enzyme labeled detection reagent for sera for different animal species. Vet Microbiol 101:123–129</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15172695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevens MG, Olsen SC, Cheville NF. Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51. Vet Immunol Immunopathol. 1995;44:223–235. doi: 10.1016/0165-2427(94)05311-F.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0165-2427(94)05311-F</ArticleId>
            <ArticleId IdType="pubmed">7747403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luna-Martinez JE, Mejia-Teran C. Brucellosis in Mexico: current status and trends. Vet Microbiol. 2002;90:19–30. doi: 10.1016/S0378-1135(02)00241-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1135(02)00241-9</ArticleId>
            <ArticleId IdType="pubmed">12414130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorneles EM, Teixeira-Carvalho A, Araujo MS, Lima GK, Martins-Filho OA, Sriranganathan N, Lage AP. T lymphocytes subsets and cytokine pattern induced by vaccination against bovine brucellosis employing S19 calfhood vaccination and adult RB51 revaccination. Vaccine. 2014;32:6034–6038. doi: 10.1016/j.vaccine.2014.08.060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.08.060</ArticleId>
            <ArticleId IdType="pubmed">25218192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Vemulapalli R, Zeytun A, Schurig GG. Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun. 2001;69:5502–5508. doi: 10.1128/IAI.69.9.5502-5508.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.9.5502-5508.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98663</ArticleId>
            <ArticleId IdType="pubmed">11500423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McEwen AD, Samuel JMD. Brucella abortus: heat stable protective antigen revealed by adjuvant and present in a rough variant strain 45/20: immunization experiments on guinea pigs. Vet Rec. 1955;67:546–548.</Citation>
        </Reference>
        <Reference>
          <Citation>McEwen AD. Experiments on contagious abortion. The immunity of cattle inoculated with vaccines of graded virulence. Vet Rec. 1940;52:815.</Citation>
        </Reference>
        <Reference>
          <Citation>Cunningham B. The effect of immaturity of the calf on immunological responses to strain 19 and killed 45/20 adjuvant vaccines. Vet Rec. 1977;101:283–285. doi: 10.1136/vr.101.14.283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/vr.101.14.283</ArticleId>
            <ArticleId IdType="pubmed">411231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodard LF, Jasman RL. Comparative efficacy of an experimental S45/20 bacterin and a reduced dose of strain 19 vaccine against bovine brucellosis. Am J Vet Res. 1983;44:907–910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6870000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schurig GG, Hammerberg C, Finkler BR. Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex. Am J Vet Res. 1984;45:967–971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6203443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivanov AV, Salmakov KM, Olsen SC, Plumb GE. A live vaccine from Brucella abortus strain 82 for control of cattle brucellosis in the Russian Federation. Anim Health Res Rev. 2011;12:113–121. doi: 10.1017/S1466252311000028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1466252311000028</ArticleId>
            <ArticleId IdType="pubmed">21676343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmakov KM, Fomin AM, Plotnikova EM, Safina GM, Galimova GM, Salmakova AV, Ivanov AV, Panin AN, Sklyarov OD, Shumilov KV, Klimanov AI (2010) Comparative study of the immunobiological properties of live brucellosis vaccines. Vaccine 28(Suppl 5):F35–40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20362201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Xu J, Xie Y, Qiu Y, Fu S, Yuan X, Ke Y, Yu S, Du X, Cui M, Chen Y, Wang T, Wang Z, Yu Y, Huang K, Huang L, Peng G, Chen Z, Wang Y (2012) Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice. Vet Microbiol 161:137–144</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22854331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu S, Xu J, Li X, Xie Y, Qiu Y, Du X, Yu S, Bai Y, Chen Y, Wang T, Wang Z, Yu Y, Peng G, Huang K, Huang L, Wang Y, Chen Z. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection. PLoS One. 2012;7 doi: 10.1371/journal.pone.0029552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029552</ArticleId>
            <ArticleId IdType="pmc">PMC3286461</ArticleId>
            <ArticleId IdType="pubmed">22383953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onate AA, Vemulapalli R, Andrews E, Schurig GG, Boyle S, Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun. 1999;67:986–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC96417</ArticleId>
            <ArticleId IdType="pubmed">9916121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, Cravero S, Calvert CL, Toth TE, Sriranganathan N, Boyle SM, Rossetti OL, Schurig GG. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Vaccine Immunol. 2000;7:114–118. doi: 10.1128/CDLI.7.1.114-118.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CDLI.7.1.114-118.2000</ArticleId>
            <ArticleId IdType="pmc">PMC95834</ArticleId>
            <ArticleId IdType="pubmed">10618289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edmonds M, Booth N, Hagius S, Walker J, Enright F, Roop RM, 2nd, Elzer P. Attenuation and immunogenicity of a Brucella abortus htrA cycL double mutant in cattle. Vet Microbiol. 2000;76:81–90. doi: 10.1016/S0378-1135(00)00225-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1135(00)00225-X</ArticleId>
            <ArticleId IdType="pubmed">10925044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang M, Han X, Liu H, Tian M, Ding C, Song J, Sun X, Liu Z, Yu S. Inactivation of the ABC transporter ATPase gene in Brucella abortus strain 2308 attenuated the virulence of the bacteria. Vet Microbiol. 2013;164:322–329. doi: 10.1016/j.vetmic.2013.02.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2013.02.017</ArticleId>
            <ArticleId IdType="pubmed">23507429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trant CG, Lacerda TL, Carvalho NB, Azevedo V, Rosinha GM, Salcedo SP, Gorvel JP, Oliveira SC. The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun. 2010;78:2283–2291. doi: 10.1128/IAI.01433-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01433-09</ArticleId>
            <ArticleId IdType="pmc">PMC2863508</ArticleId>
            <ArticleId IdType="pubmed">20194591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Niu J, Wang S, Lv Y, Wu Q. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp. Clin Vaccine Immunol. 2013;20:174–180. doi: 10.1128/CVI.00573-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00573-12</ArticleId>
            <ArticleId IdType="pmc">PMC3571281</ArticleId>
            <ArticleId IdType="pubmed">23239800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajasekaran P, Seleem MN, Contreras A, Purwantini E, Schurig GG, Sriranganathan N, Boyle SM. Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression. Applied Environ Microbiol. 2008;74:7051–7055. doi: 10.1128/AEM.01511-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.01511-08</ArticleId>
            <ArticleId IdType="pmc">PMC2583484</ArticleId>
            <ArticleId IdType="pubmed">18836016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemulapalli R, He Y, Boyle SM, Sriranganathan N, Schurig GG. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun. 2000;68:3290–3296. doi: 10.1128/IAI.68.6.3290-3296.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.68.6.3290-3296.2000</ArticleId>
            <ArticleId IdType="pmc">PMC97584</ArticleId>
            <ArticleId IdType="pubmed">10816476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramamoorthy S, Sanakkayala N, Vemulapalli R, Jain N, Lindsay DS, Schurig GS, Boyle SM, Sriranganathan N. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens. Int J Parasitol. 2007;37:1531–1538. doi: 10.1016/j.ijpara.2007.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpara.2007.04.021</ArticleId>
            <ArticleId IdType="pubmed">17575983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sabio y García JV, Bigi F, Rossetti O, Campos E (2010) Expression of MPB83 from Mycobacterium bovis in Brucella abortus S19 induces specific cellular immune response against the recombinant antigen in BALB/c mice. Microbes Infect 12:1236–1243</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20888425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sabio y García JV, Farber M, Carrica M, Cravero S, Macedo GC, Bigi F, Oliveira SC, Rossetti O, Campos E (2008) Expression of Babesia bovis rhoptry-associated protein 1 (RAP1) in Brucella abortus S19. Microbes Infect 10:635–641</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18462974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avila-Calderón E, Araiza-Villanueva M, Cancino-Diaz J, López-Villegas E, Sriranganathan N, Boyle S, Contreras-Rodríguez A (2015) Roles of bacterial membrane vesicles. Arch Microbiol 197:1–10</Citation>
        </Reference>
        <Reference>
          <Citation>Pollak CN, Delpino MV, Fossati CA, Baldi PC. Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One. 2012;7 doi: 10.1371/journal.pone.0050214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0050214</ArticleId>
            <ArticleId IdType="pmc">PMC3506553</ArticleId>
            <ArticleId IdType="pubmed">23189190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamontagne J, Butler H, Chaves-Olarte E, Hunter J, Schirm M, Paquet C, Tian M, Kearney P, Hamaidi L, Chelsky D, Moriyon I, Moreno E, Paramithiotis E (2007) Extensive cell envelope modulation is associated with virulence in Brucella abortus. J Proteome Res 6:1519–1529</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17343405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain-Gupta N, Contreras-Rodriguez A, Vemulapalli R, Witonsky SG, Boyle SM, Sriranganathan N. Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice. FEMS Immunol Med Microbiol. 2012;66:436–444. doi: 10.1111/1574-695X.12010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1574-695X.12010</ArticleId>
            <ArticleId IdType="pmc">PMC4426994</ArticleId>
            <ArticleId IdType="pubmed">23163875</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
